Amplia Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 09 Aug 24 | SellUS$273,339 | Platinum Investment Management Limited | Company | 4,164,100 | US$0.092 | |
| 06 Aug 24 | SellUS$144,905 | Pengana Capital Ltd. | Company | 1,700,000 | US$0.085 | |
| 19 Jun 24 | BuyUS$30,352 | Robert Peach | Individual | 827,268 | US$0.037 | |
| 15 May 24 | BuyUS$198,083 | Allan Moss | Individual | 5,389,000 | US$0.037 | |
| 15 May 24 | BuyUS$29,780 | Jane Bell | Individual | 810,190 | US$0.037 | |
| 15 May 24 | BuyUS$22,667 | Christopher Burns | Individual | 616,672 | US$0.037 | |
| 15 May 24 | BuyUS$69,838 | Robert Peach | Individual | 1,900,005 | US$0.037 | |
| 08 Apr 24 | SellUS$49,064 | Platinum Investment Management Limited | Company | 911,770 | US$0.054 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Public Companies | 0 | 0% |
| Private Companies | 12,369,184 | 4.5% |
| Hedge Funds | 35,337,132 | 12.9% |
| Institutions | 38,771,708 | 14.1% |
| Individual Insiders | 57,651,543 | 21% |
| General Public | 130,668,745 | 47.6% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 41.6%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 35,337,132 | US$3.5m | -10.5% | 0.1% | |||
| 18,861,500 | US$1.9m | 40% | no data | |||
| 15,200,044 | US$1.5m | 0% | 3.34% | |||
| 13,500,044 | US$1.3m | -11.2% | 2.6% | |||
| 10,071,620 | US$999.4k | 0% | 2.98% | |||
| 4,885,323 | US$484.8k | 59.3% | no data | |||
| 4,392,033 | US$435.8k | 164% | no data | |||
| 4,010,978 | US$398.0k | 98% | no data | |||
| 3,940,579 | US$391.0k | 0% | no data | |||
| 3,720,791 | US$369.2k | 18.7% | no data | |||
| 3,102,500 | US$307.9k | 51.3% | no data | |||
| 3,016,247 | US$299.3k | 0% | no data | |||
| 2,820,323 | US$279.9k | 54.8% | no data | |||
| 2,700,000 | US$267.9k | 80% | no data | |||
| 2,626,105 | US$260.6k | 93.2% | no data | |||
| 2,430,000 | US$241.1k | 0% | no data | |||
| 2,412,500 | US$239.4k | 0% | no data | |||
| 2,216,673 | US$220.0k | 0% | no data | |||
| 2,215,237 | US$219.8k | 0% | no data | |||
| 1,925,000 | US$191.0k | 0% | no data | |||
| 1,661,428 | US$164.9k | 0% | no data | |||
| 1,541,755 | US$153.0k | 111% | no data | |||
| 1,541,755 | US$153.0k | 111% | no data |